We thank Kucukseymen et al 1 for their interest in our paper entitled "Vitamin D and Dysfunctional Adipose Tissue in Obesity." 2 We assessed vitamin D levels in obese individuals and evaluated the relationship between this vitamin and adipose tissue dysfunction. 2 We showed that an increase in vitamin D level is accompanied by intensive increase in adiponectin concentrations. Therefore, we suggested that vitamin D supplementation may have a beneficial effect on obesity via modulation of adipocytokine secretion. However, a recent meta-analysis did not demonstrate such a link. 3 We mentioned that previous studies reported that intra-abdominal obesity has a direct impact on increased cardiovascular risk due to the increased action of pro-inflammatory and proatherogenic cytokines. 4, 5 Kucukseymen et al 1 mentioned that in our study, 2 there were no details about serum inflammation markers such as highsensitivity C-reactive protein (hsCRP), white blood cells, and neutrophil-to-lymphocyte ratio (NLR). Our unpublished data show that hsCRP was significantly increased (P < .001) in obese compared to nonobese, control participants (control: 0.82 + 1.28 mg/L, obese: 7.67 + 6.92 mg/L). We also measured plasma level of nitric oxide (NO) as an inflammatory marker, and our unpublished data show that the level of NO was significantly increased (P < .001) in obese compared to nonobese control participants (control: 5.67 + 4.52 mmol/L, obese: 13.75 + 9.06 mmol/L). However, we agree with the comment that even if we measure hsCRP, white blood cell, and NLR, this will not be enough because some intestinal diseases (eg, Crohn disease or celiac disease) impair dietary vitamin D absorption. 6 Kucukseymen et al 1 mention that it would be helpful to know during which season this study was carried out. The study was carried out from March to June (ie, spring). We do not have specific information about sunlight exposure and vitamin D obtained from food.
Response to Editor to the Comment "Vitamin D Trials and Their Limitations" by Kucukseymen et al
We thank Kucukseymen et al 1 for their interest in our paper entitled "Vitamin D and Dysfunctional Adipose Tissue in Obesity." 2 We assessed vitamin D levels in obese individuals and evaluated the relationship between this vitamin and adipose tissue dysfunction. 2 We showed that an increase in vitamin D level is accompanied by intensive increase in adiponectin concentrations. Therefore, we suggested that vitamin D supplementation may have a beneficial effect on obesity via modulation of adipocytokine secretion. However, a recent meta-analysis did not demonstrate such a link. 3 We mentioned that previous studies reported that intra-abdominal obesity has a direct impact on increased cardiovascular risk due to the increased action of pro-inflammatory and proatherogenic cytokines. 4, 5 Kucukseymen et al 1 mentioned that in our study, 2 there were no details about serum inflammation markers such as highsensitivity C-reactive protein (hsCRP), white blood cells, and neutrophil-to-lymphocyte ratio (NLR). Our unpublished data show that hsCRP was significantly increased (P < .001) in obese compared to nonobese, control participants (control: 0.82 + 1.28 mg/L, obese: 7.67 + 6.92 mg/L). We also measured plasma level of nitric oxide (NO) as an inflammatory marker, and our unpublished data show that the level of NO was significantly increased (P < .001) in obese compared to nonobese control participants (control: 5.67 + 4.52 mmol/L, obese: 13.75 + 9.06 mmol/L). However, we agree with the comment that even if we measure hsCRP, white blood cell, and NLR, this will not be enough because some intestinal diseases (eg, Crohn disease or celiac disease) impair dietary vitamin D absorption. 6 Kucukseymen et al 1 mention that it would be helpful to know during which season this study was carried out. The study was carried out from March to June (ie, spring). We do not have specific information about sunlight exposure and vitamin D obtained from food.
Finally, Pereira-Santos et al reported a systematic review and meta-analysis of studies that examined the relationships between vitamin D deficiency and obesity. As is in our study, they pointed out the fact that the prevalence of vitamin D deficiency was higher in obese participants compared to normal-weight participants. In addition, they concluded that the vitamin D deficiency was associated with obesity irrespective of age, latitude, and cutoff values to define vitamin D deficiency and the Human Development Index of the study location. 7 
